PreskornSH. Clinically relevant pharmacology of selective serotonin-reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Clin Pharmacokinet1997; 32(suppl 1):1–21.
2.
HermansJJRThijssenHHW. Human liver microsomal metabolism of the enantiomers of warfarin and acenocoumarol: P450 isoenzyme diversity determines the differences in their pharmacokinetics. Br J Pharmacol1993; 110:482–90.
3.
ParkerNGBrownCS. Citalopram in the treatment of depression. Ann Pharmacother2000; 34:761–71.
4.
ThijssenHHFlinoisJPBeaunePH. Cytochrome P4502C9 is the principal catalyst of racemic acenocoumarol hydroxylation reactions in human liver microsomes. Drug Metab Dispos2000; 28:1284–90.
5.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30:239–45.